Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension
Authors:
- 5 September 2022
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 173 (4) , 433-436
Abstract
The aim of the study was to evaluate the levels of cardiac biomarkers endothelin 1, B-natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptideKeywords
This publication has 15 references indexed in Scilit:
- Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19Nitric Oxide, 2020
- Cardiovascular complications of COVID-19Messenger of ANESTHESIOLOGY AND RESUSCITATION, 2020
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19New England Journal of Medicine, 2020
- COVID-19 and Cardiovascular DiseaseCirculation, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment optionsCardiovascular Research, 2020
- Inhaled NO and COVID‐19British Journal of Pharmacology, 2020
- BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic MedicineInternational Journal of Molecular Sciences, 2019
- Hypoxic Pulmonary VasoconstrictionPhysiological Reviews, 2012
- Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionEuropean Respiratory Journal, 2010